Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 504

1.

Quantification of particle-conjugated or particle-encapsulated peptides on interfering reagent backgrounds.

Yap WT, Song WK, Chauhan N, Scalise PN, Agarwal R, Miller SD, Shea LD.

Biotechniques. 2014 Jul 1;57(1):39-44. doi: 10.2144/000114190. eCollection 2014.

PMID:
25005692
[PubMed - in process]
Free Article
2.

Experimental Autoimmune Encephalomyelitis in Mice.

Terry RL, Ifergan I, Miller SD.

Methods Mol Biol. 2014 Jul 9. [Epub ahead of print]

PMID:
25005074
[PubMed - as supplied by publisher]
3.

Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).

Klaren RE, Motl RW, Woods JA, Miller SD.

J Neuroimmunol. 2014 Jun 24. pii: S0165-5728(14)00185-4. doi: 10.1016/j.jneuroim.2014.06.014. [Epub ahead of print] Review.

PMID:
24999244
[PubMed - as supplied by publisher]
4.

FERTILITY PRESERVATION IN PAEDIATRIC NEPHROLOGY: RESULTS OF A PHYSICIAN SURVEY.

Miller SD, Li Y, Meyers KE, Caplan A, Miller VA, Ginsberg JP.

J Ren Care. 2014 Jul 1. doi: 10.1111/jorc.12079. [Epub ahead of print]

PMID:
24980474
[PubMed - as supplied by publisher]
5.

γδ T cell subsets play opposing roles in regulating experimental autoimmune encephalomyelitis.

Blink SE, Caldis MW, Goings GE, Harp CT, Malissen B, Prinz I, Xu D, Miller SD.

Cell Immunol. 2014 May 10;290(1):39-51. doi: 10.1016/j.cellimm.2014.04.013. [Epub ahead of print]

PMID:
24860937
[PubMed - as supplied by publisher]
6.

Preemptive Tolerogenic Delivery of Donor Antigens for Permanent Allogeneic Islet Graft Protection.

Wang S, Zhang X, Zhang L, Bryant J, Kheradmand T, Hering BJ, Miller SD, Luo X.

Cell Transplant. 2014 Apr 22. [Epub ahead of print]

PMID:
24759564
[PubMed - as supplied by publisher]
7.

First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection.

Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, Getts DR.

Am J Transplant. 2014 Jun;14(6):1346-55. doi: 10.1111/ajt.12698. Epub 2014 Apr 17.

PMID:
24751150
[PubMed - in process]
8.

Molecular control of monocyte development.

Terry RL, Miller SD.

Cell Immunol. 2014 Mar 12. pii: S0008-8749(14)00034-3. doi: 10.1016/j.cellimm.2014.02.008. [Epub ahead of print]

PMID:
24709055
[PubMed - as supplied by publisher]
9.

Targeted immunomodulation using antigen-conjugated nanoparticles.

McCarthy DP, Hunter ZN, Chackerian B, Shea LD, Miller SD.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 May-Jun;6(3):298-315. doi: 10.1002/wnan.1263. Epub 2014 Mar 10.

PMID:
24616452
[PubMed - in process]
10.

A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.

Hunter Z, McCarthy DP, Yap WT, Harp CT, Getts DR, Shea LD, Miller SD.

ACS Nano. 2014 Mar 25;8(3):2148-60. doi: 10.1021/nn405033r. Epub 2014 Feb 27.

PMID:
24559284
[PubMed - in process]
11.

The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment.

Robinson AP, Harp CT, Noronha A, Miller SD.

Handb Clin Neurol. 2014;122:173-89. doi: 10.1016/B978-0-444-52001-2.00008-X.

PMID:
24507518
[PubMed - in process]
Free PMC Article
12.

Inducing immune tolerance: a focus on Type 1 diabetes mellitus.

Xu D, Prasad S, Miller SD.

Diabetes Manag (Lond). 2013 Sep 1;3(5):415-426.

PMID:
24505231
[PubMed]
Free PMC Article
13.

Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis.

Banisadr G, Schwartz SR, Podojil JR, Piccinini LA, Lanker S, Miller SD, Miller RJ.

J Neuroimmune Pharmacol. 2014 Jun;9(3):438-45. doi: 10.1007/s11481-014-9521-9. Epub 2014 Jan 30.

PMID:
24477403
[PubMed - in process]
14.

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles.

Getts DR, Terry RL, Getts MT, Deffrasnes C, Müller M, van Vreden C, Ashhurst TM, Chami B, McCarthy D, Wu H, Ma J, Martin A, Shae LD, Witting P, Kansas GS, Kühn J, Hafezi W, Campbell IL, Reilly D, Say J, Brown L, White MY, Cordwell SJ, Chadban SJ, Thorp EB, Bao S, Miller SD, King NJ.

Sci Transl Med. 2014 Jan 15;6(219):219ra7. doi: 10.1126/scitranslmed.3007563.

PMID:
24431111
[PubMed - in process]
15.

Immune mechanisms in epileptogenesis.

Xu D, Miller SD, Koh S.

Front Cell Neurosci. 2013 Nov 8;7:195. doi: 10.3389/fncel.2013.00195. eCollection 2013. Review.

PMID:
24265605
[PubMed]
Free PMC Article
16.

Exploiting apoptosis for therapeutic tolerance induction.

Getts DR, McCarthy DP, Miller SD.

J Immunol. 2013 Dec 1;191(11):5341-6. doi: 10.4049/jimmunol.1302070. Review.

PMID:
24244028
[PubMed - indexed for MEDLINE]
17.

Optical tomographic imaging of near infrared imaging agents quantifies disease severity and immunomodulation of experimental autoimmune encephalomyelitis in vivo.

Eaton VL, Vasquez KO, Goings GE, Hunter ZN, Peterson JD, Miller SD.

J Neuroinflammation. 2013 Nov 15;10:138. doi: 10.1186/1742-2094-10-138.

PMID:
24237884
[PubMed - indexed for MEDLINE]
Free Article
18.

Effect size calculations for the clinician: methods and comparability.

Seidel JA, Miller SD, Chow DL.

Psychother Res. 2014 Jul;24(4):470-84. doi: 10.1080/10503307.2013.840812. Epub 2013 Nov 5.

PMID:
24188906
[PubMed - in process]
19.

Earth-viewing satellite perspectives on the Chelyabinsk meteor event.

Miller SD, Straka WC 3rd, Bachmeier AS, Schmit TJ, Partain PT, Noh YJ.

Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18092-7. doi: 10.1073/pnas.1307965110. Epub 2013 Oct 21.

PMID:
24145398
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.

Smarr CB, Bryce PJ, Miller SD.

Crit Rev Immunol. 2013;33(5):389-414. Review.

PMID:
24099300
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk